Similar articles

• TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

  't Hoen E. 't Hoen E. Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
• Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.

  Buckely M. Buckely M. Seton Hall Law Rev. 2011;41(2):625-69. Seton Hall Law Rev. 2011. PMID: 21739760 No abstract available.
• The Health Impact Fund: incentives for improving access to medicines.

  Banerjee A, Hollis A, Pogge T. Banerjee A, et al. Lancet. 2010 Jan 9;375(9709):166-9. doi: 10.1016/S0140-6736(09)61296-4. Lancet. 2010. PMID: 20109894 No abstract available.
• The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.

  Openshaw MS. Openshaw MS. Nurs Econ. 2005 Nov-Dec;23(6):307-11, 279. Nurs Econ. 2005. PMID: 16459902 Review.
• Should the patent system for pharmaceuticals be replaced? A theoretical approach.

  Antoñanzas F, Rodríguez-Ibeas R, Juárez-Castelló CA. Antoñanzas F, et al. Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):617-26. doi: 10.1586/14737167.2014.927315. Epub 2014 Jun 17. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24934980 Review.